Synopsis:
The manuscript reviewed the 12 yrs (1992 – 2004) of research done on dibenzyl trisulphide (DTS) as a
potential therapeutic agent. These studies revealed that DTS could be useful in the treatment of cancers, immunological disorders and memory loss.